post-1

Mesothelioma Alert | 9/11 dust still causing health concerns for Ground Zero workers

First responders, volunteers, and residents continue to report pulmonary problems

post-1

9-11 CONTINUES TO CAUSE HEALTH-RELATED HAVOC

First responders and others caught in the mayhem of 9-11 still suffer ill health

Patients currently being recruited for Phase II of the IMC-A12 in Patients with Mesothelioma study

Mesothelioma patients treated previously with chemotherapy may be eligible for inclusion in the study sponsored by the National Cancer Institute

Beijing, China welcomes the 2010 World Cancer Congress from August 18th through the 21st

The World Cancer Congress to offer the opportunity to join Asian and International colleagues in cancer control to network and exchange knowledge and best practices

Ongoing study explores the use of surgery and photodynamic therapy in treating patients with malignant mesothelioma

The Roswell Park Cancer Institute, in collaboration with the National Cancer Institute, enters phase II of a study in Buffalo, New York combining photodynamic therapy and surgery

The Cancer Nurse Society of Australia’s 13th Winter Congress addressed leadership, innovation and advanced practice, among other topics

Over three days in July cancer nurses from around Australia congregated in Perth for workshops, plenary sessions and poster presentations

post-1

Mesothelioma Alert: Second Annual WIN Symposium to present breakthrough scientific technologies and accomplishments in personalized cancer medicine

Academia and industry unite to improve early cancer diagnosis from July 7th to the 9th, 2010

Cancer Conference Alert: Emerging Trends in Oncology Educational Programme Conference to be held on June 30, 2010

Important oncologic issues covered at a conference held via satellite in eight different locations around the United Kingdom

Cancer Pain Alert: Fentanyl Sublingual Spray clinical trial is now recruiting patients with breakthrough cancer pain

Study sponsored by Insys Therapeutics Inc. may lead to incredible developments for the treatment of patients who are receiving opioids for cancer pain

Cancer alert: MD Anderson Cancer Center to host annual workshop, bringing together leading oncologists, medical experts

The 8th Annual Disparities in Health in America workshop set to spread knowledge of bio-psychosocial approaches in cancer treatment

Pemetrexed plus Gemcitabine or Carboplatin clinical trial for Mesothelioma continues to test efficacy of anti-cancer chemotherapy drugs

Sponsor Eastern Cooperative Oncology Group, in collaboration with the National Cancer Institute North Central Cancer Treatment Group, is currently conducting a trial for patients with malignant pleural mesothelioma

Pleural Mesothelioma Alert: CBP501, pemetrexed and cisplatin clinical trial now recruiting patients with solid tumors and pleural mesothelioma

A study sponsored by CanBas, Co. Ltd. may lead to crucial breakthroughs in the treatment of mesothelioma

post-1

"A Decade in General Thoracic Surgery, Lessons Learned...Lessons Taught" to be presented at Brigham and Women’s June 9th

Annual Richard E. Wilson Visiting Professor in Thoracic Surgery Sudish Murthy, M.D. to speak at Brigham and Women’s Hospital Department of Surgery Grand Rounds

Peritoneal Mesothelioma Cancer Alert: Surgery, Chemotherapy and Radiation Therapy Treatment Clinical Trial is ongoing

Sponsor Herbert Irving Comprehensive Cancer Center collaborates with the National Cancer Institute in a medical trial for patients with peritoneal mesothelioma

post-1

Mesothelioma Clinical Trial Alert: Pemetrexed (Alimta®) plus Cisplatin® trial seeking stage II participants

Phase II clinical trial sponsored by Eli Lilly

Cancer Alert: Risk of exposure to carcinogens in our daily lives “underestimated,” say experts

President’s Cancer Panel believes that the public, especially parents, lack information about “common cancer risks”

Earth Day Reminder: Asbestos Still Presents a Hazard to Our Planet’s Inhabitants

Toxic Asbestos Still Found in Older Homes and Buildings

Mesothelioma & Mining Alert: Tougher mining regulations by EPA face opposition from West Virginia

The EPA says it will implement “much tougher” standards related to water quality at mine sites, starting immediately

Mesothelioma Cancer Alert: Camp Good Days and Special Times to offer Women’s Oncology Program

Since 1996, the camp has offered camping experiences for women with different forms of cancer

Mesothelioma Alert: Alimta® plus Cisplatin clinical trial now recruiting participants

Sponsored by Eli Lilly, the trial will study patients with malignant mesothelioma cancer